NuVasive (NUVA) PT Raised to $84 at Jefferies Following Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- S&P 500, Dow on course for slim gains at open as Iran tensions clash with AI optimism
- Oil prices fall after hitting over one-month high; traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
NuVasive (NUVA) PT Raised to $82 at UBS
February 10, 2017 9:19 AM ESTUBS analyst Matt Miksic reiterates Buy rating and raises price target on NuVasive Inc. (NASDAQ: NUVA) to $82 (from $71), as the companys sales surpass pre-announcement, driven by a one-time order, while management makes progress on margins.
Miksic comments, "Management delivered upside to the company's... More
NuVasive (NUVA) PT Raised to $80 at Barclays
February 10, 2017 8:46 AM ESTBarclays raised its price target on NuVasive (NASDAQ: NUVA) to $80.00 (from $76.00) while maintaining a Overweight rating.
... MoreNuVasive (NUVA) Hold Rating Maintained at Needham & Company Despite Growth Rebound
February 10, 2017 6:48 AM ESTNeedham & Company analyst Mike Matson reiterates Hold rating on NuVasive Inc. (NASDAQ: NUVA), suggesting growth recovered in the fourth quarter of 2016 and now sees multiple levels for growth and margins in 2017.
Matson writes, "NUVA's 4Q16 revenue beat its 1/9/17 preannouncement and EPS beat consensus. And... More
NuVasive (NUVA) Tops Q4 EPS by 2c
February 9, 2017 4:30 PM ESTNuVasive (NASDAQ: NUVA) reported Q4 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $271.1 million versus the consensus estimate of $261.47 million.
For earnings history and earnings-related data on NuVasive (NUVA) click here.
... More